CAV1 and Familial prostate cancer: Further studies are needed to address the role of Cav1 for radiosensitivity of prostate cancer epithelial cells and to develop and validate the use of pharmacological strategies to reduce Cav1 expression or inhibit resistance-promoting Cav1-dependent signals, respectively.